Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 15/20 | 0.65 |
| ▸ | ITGA4 | P13612 | 15/20 | 0.65 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700904 | 0.93 | ITGB1 (0.70) | ITGB1ITGA4ITGB7P2RX7MEN1 | |
| SCHEMBL5700900 | 0.93 | ITGB1 (0.70) | ITGB1ITGA4ITGB7P2RX7MEN1 | |
| SCHEMBL5700782 | 0.92 | ITGB1 (0.65) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL5701016 | 0.90 | ITGB1 (0.78) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL5700979 | 0.90 | ITGB1 (0.78) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL5701003 | 0.89 | ITGB1 (0.66) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL5700855 | 0.89 | ITGB1 (0.64) | ITGB1ITGA4ITGB7P2RX7MEN1 | |
| SCHEMBL5701046 | 0.89 | ITGB1 (0.64) | ITGB1ITGA4ITGB7P2RX7MEN1 | |
| SCHEMBL5700985 | 0.89 | ITGB1 (0.77) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| Water SCHEMBL5701072 | 0.89 | ITGB1 (0.77) | ITGB1ITGA4ITGB7MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1027328-B1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LTD (GB) | 2006-08-23 | — | — | EP | disclosed |
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1027328-A1 | SUBSTITUTED ANILIDES | Aventis Pharma Limited (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023063-A1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LIMITED (GB) | 1999-05-14 | — | — | WO | disclosed |